An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer
Figure 7
Concentration of Cmpd-1 in serum collected at the time of culling plotted against the time since last dose of Cmpd-1.